Total Payments
$140,052
2024 Payments
$13,235
Companies
11
Transactions
343
Medicare Patients
655
Medicare Billing
$27,342
Payment Breakdown by Category
Other$70,250 (50.2%)
Consulting$38,570 (27.5%)
Travel$25,142 (18.0%)
Food & Beverage$5,906 (4.2%)
Education$183.90 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $70,250 | 40 | 50.2% |
| Consulting Fee | $38,570 | 11 | 27.5% |
| Travel and Lodging | $25,142 | 84 | 18.0% |
| Food and Beverage | $5,906 | 204 | 4.2% |
| Education | $183.90 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $104,508 | 158 | $0 (2024) |
| ViiV Healthcare Company | $31,568 | 87 | $0 (2024) |
| Janssen Products, LP | $2,575 | 8 | $0 (2021) |
| Janssen Biotech, Inc. | $1,193 | 79 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $56.96 | 2 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $47.55 | 3 | $0 (2018) |
| Hologic Sales and Service, LLC | $29.45 | 1 | $0 (2023) |
| Theratechnologies Inc. | $23.28 | 2 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $18.54 | 1 | $0 (2023) |
| Hologic, LLC | $18.34 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,235 | 23 | Gilead Sciences, Inc. ($13,127) |
| 2023 | $19,654 | 56 | Gilead Sciences, Inc. ($13,736) |
| 2022 | $11,671 | 42 | ViiV Healthcare Company ($5,693) |
| 2021 | $10,736 | 24 | Gilead Sciences, Inc. ($7,689) |
| 2020 | $7,526 | 29 | ViiV Healthcare Company ($3,939) |
| 2019 | $28,488 | 66 | Gilead Sciences, Inc. ($21,600) |
| 2018 | $21,915 | 50 | Gilead Sciences, Inc. ($16,820) |
| 2017 | $26,827 | 53 | Gilead Sciences Inc ($22,458) |
All Payment Transactions
343 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: HIV | ||||||
| 12/04/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,360.00 | General |
| Category: HIV | ||||||
| 12/04/2024 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,386.00 | General |
| 12/02/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $583.66 | General |
| Category: HIV | ||||||
| 12/02/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $205.45 | General |
| Category: HIV | ||||||
| 12/02/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $169.50 | General |
| Category: HIV | ||||||
| 12/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $121.83 | General |
| 12/02/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $33.43 | General |
| Category: HIV | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $583.65 | General |
| 11/07/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $205.45 | General |
| 11/07/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $169.50 | General |
| 09/06/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: HIV | ||||||
| 07/24/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: HIV | ||||||
| 05/14/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: HIV | ||||||
| 04/20/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,210.00 | General |
| Category: HIV | ||||||
| 04/10/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: HIV | ||||||
| 04/05/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: HIV | ||||||
| 04/05/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $20.47 | General |
| Category: HIV | ||||||
| 04/04/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $458.08 | General |
| Category: HIV | ||||||
| 04/04/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $312.55 | General |
| Category: HIV | ||||||
| 04/04/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $257.00 | General |
| Category: HIV | ||||||
| 03/05/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: HIV | ||||||
| 02/22/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: HIV | ||||||
| 12/26/2023 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: HIV | ||||||
| 12/15/2023 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $370.00 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 12 | 306 | 354 | $18,911 | $13,040 |
| 2020 | 12 | 349 | 394 | $20,504 | $14,302 |
Total Patients
655
Total Services
748
Medicare Billing
$27,342
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87536 | Detection test by nucleic acid for hiv-1 virus, quantification | Office | 2021 | 43 | 67 | $8,040 | $5,702 | 70.9% |
| 86360 | T cell count and ratio, including ratio | Office | 2021 | 41 | 65 | $5,200 | $3,054 | 58.7% |
| 86480 | Tuberculosis test, gamma interferon | Office | 2021 | 25 | 25 | $1,625 | $1,550 | 95.4% |
| 87491 | Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | Office | 2021 | 12 | 12 | $480.00 | $421.08 | 87.7% |
| 87591 | Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | Office | 2021 | 12 | 12 | $480.00 | $421.08 | 87.7% |
| 86803 | Hepatitis c antibody measurement | Office | 2021 | 26 | 26 | $650.00 | $371.02 | 57.1% |
| 86708 | Measurement of hepatitis a antibody | Office | 2021 | 26 | 26 | $468.00 | $322.14 | 68.8% |
| 86704 | Hepatitis b core antibody measurement | Office | 2021 | 26 | 26 | $468.00 | $313.30 | 66.9% |
| 86706 | Hepatitis b surface antibody measurement | Office | 2021 | 26 | 26 | $468.00 | $279.24 | 59.7% |
| 86709 | Measurement of hepatitis a antibody (igm) | Office | 2021 | 23 | 23 | $414.00 | $258.98 | 62.6% |
| 87340 | Detection test by immunoassay technique for hepatitis b surface antigen | Office | 2021 | 25 | 25 | $450.00 | $258.25 | 57.4% |
| 86592 | Syphilis detection test | Office | 2021 | 21 | 21 | $168.00 | $89.67 | 53.4% |
| 87536 | Detection test for hiv-1 virus | Office | 2020 | 43 | 62 | $7,440 | $5,237 | 70.4% |
| 86360 | T cell count and ratio | Office | 2020 | 50 | 71 | $5,680 | $3,309 | 58.3% |
| 86480 | Tuberculosis test | Office | 2020 | 30 | 30 | $1,950 | $1,841 | 94.4% |
| 87491 | Detection test for chlamydia | Office | 2020 | 30 | 32 | $1,280 | $1,112 | 86.9% |
| 87591 | Detection test for neisseria gonorrhoeae (gonorrhoeae bacteria) | Office | 2020 | 29 | 31 | $1,240 | $1,077 | 86.9% |
| 86803 | Hepatitis c antibody measurement | Office | 2020 | 28 | 28 | $700.00 | $395.50 | 56.5% |
| 86708 | Measurement of hepatitis a antibody | Office | 2020 | 26 | 26 | $468.00 | $318.64 | 68.1% |
| 86704 | Hepatitis b core antibody measurement | Office | 2020 | 25 | 25 | $450.00 | $297.89 | 66.2% |
| 86706 | Hepatitis b surface antibody measurement | Office | 2020 | 27 | 27 | $486.00 | $286.83 | 59.0% |
| 87340 | Detection test for hepatitis b surface antigen | Office | 2020 | 27 | 27 | $486.00 | $275.76 | 56.7% |
| 86593 | Syphilis test | Office | 2020 | 21 | 22 | $220.00 | $95.63 | 43.5% |
| 86592 | Syphilis detection test | Office | 2020 | 13 | 13 | $104.00 | $55.33 | 53.2% |
About Dr. Ryan Zane, MD
Dr. Ryan Zane, MD is a Public Health or Welfare healthcare provider based in San Bernardino, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669534293.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Zane, MD has received a total of $140,052 in payments from pharmaceutical and medical device companies, with $13,235 received in 2024. These payments were reported across 343 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($70,250).
As a Medicare-enrolled provider, Zane has provided services to 655 Medicare beneficiaries, totaling 748 services with total Medicare billing of $27,342. Data is available for 2 years (2020–2021), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Public Health or Welfare
- Other Specialties Public Health & General Preventive Medicine
- Location San Bernardino, CA
- Active Since 12/13/2006
- Last Updated 01/09/2008
- Taxonomy Code 251K00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669534293
Products in Payments
- Biktarvy (Drug) $37,114
- DOVATO (Drug) $7,023
- CABENUVA (Biological) $5,260
- Genvoya (Drug) $5,008
- TIVICAY (Drug) $4,681
- Symtuza (Drug) $2,420
- SYMTUZA (Drug) $1,124
- TRIUMEQ (Drug) $137.68
- RUKOBIA (Drug) $50.02
- JULUCA (Drug) $37.91
- THINPREP 2000 PROCESSOR (Device) $29.45
- PREZCOBIX (Drug) $26.99
- TROGARZO (Drug) $23.28
- ISENTRESS (Drug) $19.25
- APTIMA (Device) $18.34
- VIVITROL (Drug) $13.59
- NEXPLANON (Drug) $12.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.